A method of forming a biosensor is provided. The method includes providing a substrate and a cover including first and second surfaces, positioning a reagent on the substrate, carving a channel by laser ablation in the first surface, and coupling the first surface of the cover to the second surface. The channel includes a first portion having a first height and a second portion having a second height that is less than the first height.

Patent
   6911621
Priority
Nov 01 2000
Filed
Jan 08 2003
Issued
Jun 28 2005
Expiry
Jun 01 2021
Extension
212 days
Assg.orig
Entity
Large
127
120
EXPIRED
1. A method of forming a biosensor, the method comprising the steps of:
providing a substrate and a cover including first and second surfaces,
positioning a reagent on the substrate,
carving a flow channel and at least one secondary channel by laser ablation in the first surface, and
coupling the first surface of the cover to the second surface so that the flow channel is aligned with at least a portion of the reagent.
11. A method of forming a biosensor, the method comprising the steps of:
providing a substrate and a cover including first and second surfaces,
positioning a reagent on the substrate,
carving a channel by laser ablation in the first surface, the channel including a first portion having a first height and a second portion having a second height that is less than the first height, and
coupling the first surface of the cover to the second surface.
17. A method of forming a biosensor, the method comprises the steps of:
providing a substrate and a cover having first and second surfaces,
applying a reagent onto the substrate to define a reaction zone,
carving a channel by laser ablation in the first surface of the cover so that the channel includes at least one floor portion and walls extending from the at least one floor portion, and
coupling the cover on the substrate so that the floor portion faces the substrate and the channel extends over at least a portion of the reagent.
2. The method of claim 1, wherein the cover includes opposite ends and the carving step includes carving the flow channel to extend between the ends.
3. The method of claim 2, wherein a first portion of the channel is carved to have a first height and a second portion is carved to have a second height that is less than the first height.
4. The method of claim 3, wherein the first portion is carved to include side walls that converge from one of the ends toward the second portion of the flow channel.
5. The method of claim 1, further comprising the step of positioning an adhesive in the at least one secondary channel.
6. The method of claim 1, wherein at least one secondary channel is carved in the first surface on each side of the flow channel.
7. The method of claim 6, further comprising the step of positioning an adhesive in the secondary channels.
8. The method of claim 1, further comprising the step of positioning electrodes on the substrate.
9. The method of claim 8, wherein the electrodes are formed by laser ablation.
10. The method of claim 8, wherein the first surface of the cover is coupled to the channel so that the channel extends across at least a portion of the electrodes.
12. The method of claim 11, further comprising the step of positioning electrodes on the substrate.
13. The method of claim 12, wherein the electrodes are formed by laser ablation.
14. The method of claim 12, wherein the coupling step includes aligning the channel with the electrodes so that the channel extends across at least a portion of the electrodes.
15. The method of claim 11, wherein secondary channels are carved in the cover.
16. The method of claim 11, wherein the first portion is carved to include walls that converge toward the second portion of the channel.
18. The method of claim 17, further comprising the step of forming an electrode set in the reaction zone.
19. The method of claim 18, wherein the electrode set is formed by laser ablation.
20. The method of claim 17, wherein secondary channels are carved in the first surface of the cover.

This application is a continuation of U.S. Pat. No. 6,540,890 issued on Apr. 1, 2003.

The present invention relates to a biosensor and particularly to biosensor that includes a channeled cover.

Electrochemical biosensors are known. They have been used to determine the concentration of various analytes from biological samples, particularly from blood. Biosensors are described in U.S. Pat. Nos. 5,413,690; 5,762,770; 5,798,031; and 5,997,817, the disclosure of each of which are expressly incorporated herein by reference.

Laser ablation is a known technique that uses a laser to remove a material. See, for example, U.S. Pat. Nos. 5,576,073 and 5,593,739 and International WO98/35225, the disclosure of each of which is expressly incorporated herein by reference. Such known laser ablation systems use a high power excimer laser, such as a krypton fluoride excimer laser with an illumination wavelength of 248 nanometers, to remove surface material.

According to the present invention a biosensor is provided. The biosensor comprises a substrate, a reagent positioned on the substrate, and a cover. The cover includes a first surface coupled to the substrate and a second surface. The first surface has a flow channel carved therein that extends over at least a portion of the reagent.

According to another aspect of the present invention, a biosensor is provided. The biosensor comprises a substrate, a reagent positioned on the substrate, and a cover coupled to the substrate. The cover includes opposite ends, a first surface coupled to the substrate, and a second surface. The first surface has a flow channel carved therein. The flow channel extends between the opposite ends.

In still another aspect of the present invention, a method of forming a biosensor is provided. The method comprises the steps of providing a substrate and a cover that has first and second surfaces, applying a reagent onto the substrate to define a reaction zone, carving a channel in the first surface of the cover, and coupling the cover on the substrate so that the channel extends over at least a portion of the reagent.

Additional features of the invention will become apparent to those skilled in the art upon consideration of the following detailed description of the preferred embodiment exemplifying the best mode of carrying out the invention

The detailed description particularly refers to the accompanying figures in which:

FIG. 1 is an exploded assembly view of an electrochemical biosensor in accordance with the present invention showing the biosensor including a substrate, a reagent, and a cover;

FIG. 2 is a bottom perspective view of the cover FIG. 1;

FIG. 3 is an end view of the biosensor of FIG. 1;

FIG. 4 is a view taken along lines 44 of FIG. 1;

FIG. 5 is a view taken along lines 55 of FIG. 1;

FIG. 6 is an exploded assembly view of a biosensor in accordance with another aspect of the invention, showing the biosensor including a substrate, a reagent, and cover;

FIG. 7 is a bottom perspective view of the cover of FIG. 6;

FIG. 8 is an end view of the biosensor of FIG. 6;

FIG. 9 is a view taken along lines 99 of FIG. 6; and

FIG. 10 is a perspective view of a biosensor in accordance with another aspect of the invention.

A biosensor 10 in accordance with the present invention provides a cover with at least one channel carved therein. The channel may be used in a variety of diagnostic biosensors including, for example, electrochemical and photometric sensors. The purpose of the channel is to provide precise fluidic channels for disposable diagnostic tests with high dimensional precision. Various aspects of the invention are presented in FIGS. 1-9, which are not drawn to scale and wherein like components in the several views are numbered alike.

FIGS. 1-5 illustrate an aspect of the invention in the form of an electrochemical biosensor 10 having a cover 12, a bottom substrate 14, electrically conductive tracks 16, 18, and a reagent 20 extending over a portion of tracks 16, 18. Biosensor 10 is preferably rectangular in shape. It is appreciated, however, that biosensor 10 can assume any number of shapes in accordance with this disclosure. Biosensor 10 is preferably produced from rolls of material, however, it is understood that biosensor 10 can be constructed from individual sheets in accordance with this disclosure. Thus, the selection of materials for the construction of biosensor 10 necessitates the use of materials that are sufficiently flexible for roll processing, but which are still rigid enough to give a useful stiffness to finished biosensor 10.

Cover 12 of biosensor 10 includes a first surface 48 facing substrate 14 and an opposite second surface 50. See FIGS. 1-2. In addition, cover 12 has opposite ends 52, 54 and edges 56, 58 extending between ends 52, 54. End 52 has a generally concave portion 60 that extends between edges 56, 58 in order to accommodate a user's finger. Preferably, cover 12 is formed of a flexible polymer and preferably from a polymer such as a polyester. A non-limiting example of a suitable polymer is 7 mil thick ST505 MELINEX® polyester film commercially available from E.I. DuPont de Nemours, Wilmington, Del. Cover 12 is coupled to substrate 14 by a liquid adhesive. A non-limiting example of such an adhesive is EPO-TEK OH100-4 commercially available from Epoxy Technology, Billerica, Mass. It is appreciated that cover 12 may be coupled to bottom substrate 14 using a wide variety of commercially available adhesives in accordance with this disclosure.

Additionally, as shown in FIG. 2, a flow channel 62 is carved in first surface 48 of cover 12. As used throughout the specification and claims, the term “carve” is defined as to make or get by cutting into a surface, thereby hollowing out a pre-determined space in that surface. Channel 62 extends between ends 52, 54. Channel 62 includes a first floor portion 36 and a second floor portion 38. In addition, opposite walls 46 extend from first floor portion 36 and opposite walls 40 extend from second floor portion 38. See FIG. 2. First floor portion 36 and walls 46 define a first portion 72 of channel 62 and second floor portion 38 and walls 40 define a second portion 74 of channel 62. Walls 46 have a first height as shown by arrows 42 and walls 40 have a second height as shown by arrows 44. First height 42 is greater than the second height 44, so that a liquid sample traveling in channel 62 encounters increasing capillary forces as the sample enters second portion 74 of channel 62. Therefore, channel 62 facilitates movement of the liquid sample away from concave portion 60 and toward reagent 20 positioned spaced-apart from end 52.

The height of walls 46 in first channel portion 36 is dependent upon the choice of the overall thickness of cover 12, but generally ranges from about 1 μm to about 150 μm. Preferably, the height of walls 46 is from about 75 μm to about 120 μm, and most preferably about 84 μm. The height of walls 40 in second channel portion 38 is also dependent upon the choice of the overall thickness of cover 12, but generally ranges from about 1 μm to about 75 μm. Preferably the height of walls 40 is from about 5 μm to about 50 μm, most preferably about 25 μm. The channel portion 38 is approximately 1000 μm to about 4000 μm wide, preferably about 2000 μm to about 3000 μm wide, and most preferably about 2500 μm wide. It is appreciated that channel 62 may be formed with a single height or width, or that it may have a variety of heights and widths in accordance with this disclosure so long as the channel meets the design goals for capillarity, meaning that the movement of the liquid sample is facilitated from portion 60 toward reagent 20.

Cover 12 of biosensor 10 also includes secondary channels 64 carved on either side of flow channel 62. Each secondary channel 64 extends between ends 52, 54 and is defined by a floor 66 and walls 68 extending from floor 66. Walls 68 have a height that is less than the second height 44. In addition, an adhesive-dispense aperture 70 extends between floor 66 and surface 50. The height of walls 68 may also vary depending upon the overall thickness of cover 12, but generally ranges from about 8 μm to about 125 μm. Preferably, the height of walls 68 is from about 8 μm to about 75 μm, most preferably about 16 μm. It is appreciated that the shape and height of walls 68 may vary in accordance with this disclosure. Moreover, it is appreciated that cover 12 may be formed with greater or fewer than two secondary channels in accordance with this disclosure.

Bottom substrate 14 of biosensor 10 includes a first surface 22 that supports conductive tracks 16, 18 and an opposite second surface 24. See FIGS. 3-4. In addition, substrate 14 has opposite ends 26, 28 and edges 30, 32 extending between ends 26, 28. See FIG. 1. First end 26 includes a concave portion 76 that is formed with alignment with concave portion 60 of cover 12, to accommodate a user's finger. It is appreciated, however, that the design of portion 76 may vary in accordance with this disclosure. Bottom element 14 may be constructed from a wide variety of insulative materials. Non-limiting examples of insulative materials that provide desirable structural properties include glass, ceramics, vinyl polymers, polyimides, polyesters, and styrenics. Preferably, bottom element 14 is a flexible polymer, such as a polyester or polyimide. A non-limiting example of a suitable material is 5 mil thick KALADEX®, a polyethylene naphthalate film commercially available from E.I. DuPont de Nemours, Wilmington, Del., which is coated with gold by LPKF Laser Electronic GmbH, of Garbsen, Germany.

Biosensors 10 in accordance with the present invention are each formed to include a pre-defined reaction area 78 where the sensing takes place. When the biosensor is electrochemical, the pre-defined area is an electrochemical area that is located on a portion of the electrodes 16, 18. Referring now to FIG. 1, biosensor 10 includes an electrochemical reaction area 78, which is defined as the area of electrodes where reagent 20 is located. Recesses 34 are formed in substrate 14 of biosensor 10 and extend about area 78. It is appreciated that recesses 34 can take on any number of shapes and sizes in accordance with this disclosure. The method of forming recesses in substrate 14 is not limited. For example, the recesses may be formed by indenting, embossing, etching (e.g., using photolithographic methods or laser removal of a portion of the base material), or otherwise deforming or removing a portion of the base material. For a further description of the laser removal of suitable recesses, see U.S. Pat. No. 6,540,890 B1 entitled BIOSENSOR to Bhullar et al., which was filed in the U.S. Patent and Trademark Office on Oct. 6, 2000, the disclosure of which is expressly incorporated herein by reference.

As shown in FIG. 1, electrically conductive tracks 16, 18 are created or isolated on first surface 24 of bottom element 14. Tracks 16, 18 represent the electrodes of biosensor 10. As used herein, the phrase “electrode set” is a set of at least two electrodes, for example 2 to 200, or 3 to 20, electrodes. These electrodes may, for example, be a working electrode and an auxiliary electrode. Tracks 16, 18 cooperate to form an interdigitated electrode array 80 positioned within the periphery of recesses 34 and leads 82 that extend from array 80 and between recesses 34 toward end 28.

Tracks 16, 18 are constructed from electrically conductive materials. Non-limiting examples of electrically-conductive materials include aluminum, carbon (such as graphite), cobalt, copper, gallium, gold, indium, iridium, iron, lead, magnesium, mercury (as an amalgam), nickel, niobium, osmium, palladium, platinum, rhenium, rhodium, selenium, silicon (such as highly doped polycrystalline silicon), silver, tantalum, tin, titanium, tungsten, uranium, vanadium, zinc, zirconium, mixtures thereof, and alloys, oxides, or metallic compounds of these elements. Preferably, tracks include gold, platinum, palladium, iridium, or alloys of these metals, since such noble metals and their alloys are unreactive in biological systems. Most preferably, track 16 is a working electrode made of gold, and track 18 is an auxiliary electrode that is also made of gold and is substantially the same size as the working electrode.

Tracks 16, 18 are isolated from the rest of the electrically conductive surface by laser ablation. Techniques for forming electrodes on a surface using laser ablation are known. See, for example, U.S. patent application Ser. No. 09/411,940, filed Oct. 4, 1999, and entitled “LASER DEFINED FEATURES FOR PATTERNED LAMINATES AND ELECTRODE”, the disclosure of which is expressly incorporated herein by reference. Tracks 16, 18 are preferably created by removing the electrically conductive material from an area extending around the electrodes. Therefore, tracks 16, 18 are isolated from the rest of the electrically-conductive material on substrate 14 by a gap having a width of about 25 μm to about 500 μm, preferably the gap has a width of about 100 μm to about 200 μm. Alternatively, it is appreciated that tracks 16, 18 may be created by laser ablation alone on bottom substrate 14. Further, tracks 16, 18 may be laminated, screen-printed, or formed by photolithography in accordance with this disclosure.

Multi-electrode arrangements are also possible in accordance with this disclosure. For example, it is contemplated that a biosensor may be formed that that includes an additional electrically conductive track (not shown). In a three-electrode arrangement, the first track is a working electrode, the second is a counter electrode, and the third electrode is a reference electrode. It is also appreciated that an alternative three-electrode arrangement is possible where tracks are working electrodes and a third electrode is provided as an auxiliary or reference electrode in accordance with this disclosure. It is appreciated that the number of tracks, as well as the spacing between tracks in array 80 may vary in accordance with this disclosure and that a number of arrays may be formed as will be appreciated by one of skill in the art.

Reagent 20 provides electrochemical probes for specific analytes and is applied onto bottom substrate 14 such that reagent 20 covers array 80. The choice of specific reagent 20 depends on the specific analyte or analytes to be measured, and are well known to those of ordinary skill in the art. An example of a reagent that may be used in biosensor 10 of the present invention is a reagent for measuring glucose from a whole blood sample. A non-limiting example of a reagent for measurement of glucose in a human blood sample contains 62.2 mg polyethylene oxide (mean molecular weight of 100-900 kilo Daltons), 3.3 mg NATROSOL 244M, 41.5 mg AVICEL RC-591 F, 89.4 mg monobasic potassium phosphate, 157.9 mg dibasic potassium phosphate, 437.3 mg potassium ferricyanide, 46.0 mg sodium succinate, 148.0 mg trehalose, 2.6 mg TRITON X-100 surfactant, and 2,000 to 9,000 units of enzyme activity per gram of reagent. The enzyme is prepared as an enzyme solution from 12.5 mg coenzyme PQQ and 1.21 million units of the apoenzyme of quinoprotein glucose dehydrogenase. This reagent is further described in U.S. Pat. No. 5,997,817, the disclosure of which is expressly incorporated herein by reference.

When hematocrit is to be determined, the reagent includes oxidized and reduced forms of a reversible electroactive compound (potassium hexacyanoferrate (III) (“ferricyanide”) and potassium hexacyanoferrate (II) (“ferrocyanide”), respectively), an electrolyte (potassium phosphate buffer), and a microcrystalline material (Avicel RC-591F—a blend of 88% microcrystalline cellulose and 12% sodium carboxymethyl-cellulose, available from FMC Corp.). Concentrations of the components within the reagent before drying are as follows: 400 millimolar (mM) ferricyanide, 55 mM ferrocyanide, 400 mM potassium phosphate, and 2.0% (weight: volume) Avicel. A further description of the reagent for a hematocrit assay is found in U.S. Pat. No. 5,385,846, the disclosure of which is expressly incorporated herein by reference.

Non-limiting examples of enzymes and mediators that may be used in measuring particular analytes in sensor 10 of the present invention are listed below in Table 1.

TABLE I
Mediator Additional
Analyte Enzymes (Oxidized Form) Mediator
Glucose Glucose Ferricyanide
Dehydrogenase
and Diaphorase
Glucose Glucose- Ferricyanide
Dehydrogenase
(Quinoprotein)
Cholesterol Cholesterol Ferricyanide 2,6-Dimethyl-1,4-
Esterase and Benzoquinone
Cholesterol 2,5-Dichloro-1,4-
Oxidase Benzoquinone or
Phenazine
Ethosulfate
HDL Cholesterol Ferricyanide 2,6-Dimethyl-1,4-
Cholesterol Esterase and Benzoquinone
Cholesterol 2,5-Dichloro-1,4-
Oxidase Benzoquinone or
Phenazine
Ethosulfate
Triglycerides Lipoprotein Ferricyanide or Phenazine
Lipase, Glycerol Phenazine Methosulfate
Kinase, and Ethosulfate
Glycerol-3-
Phosphate
Oxidase
Lactate Lactate Oxidase Ferricyanide 2,6-Dichloro-1,4-
Benzoquinone
Lactate Lactate Ferricyanide
Dehydrogenase Phenazine
and Diaphorase Ethosulfate, or
Phenazine
Methosulfate
Lactate Diaphorase Ferricyanide Phenazine
Dehydrogenase Ethosulfate, or
Phenazine
Methosulfate
Pyruvate Pyruvate Oxidase Ferricyanide
Alcohol Alcohol Oxidase Phenylenediamine
Bilirubin Bilirubin Oxidase 1-Methoxy-
Phenazine
Methosulfate
Uric Acid Uricase Ferricyanide

In some of the examples shown in Table 1, at least one additional enzyme is used as a reaction catalyst. Also, some of the examples shown in Table 1 may utilize an additional mediator, which facilitates electron transfer to the oxidized form of the mediator. The additional mediator may be provided to the reagent in lesser amount than the oxidized form of the mediator. While the above assays are described, it is contemplated that current, charge, impedance, conductance, potential, or other electrochemically indicated property of the sample might be accurately correlated to the concentration of the analyte in the sample with biosensor 10 in accordance with this disclosure.

A plurality of biosensors 10 are typically packaged in a vial, usually with a stopper formed to seal the vial. It is appreciated, however, that biosensors 10 may be packaged individually, or biosensors can be folded upon one another, rolled in a coil, stacked in cassette magazine, or packed in a blister packaging.

Biosensor 10 is used in conjunction with the following:

1. a power source in electrical connection with tracks 16, 18 and capable of supplying an electrical potential difference between the electrodes sufficient to cause diffusion limited electro-oxidation of the reduced form of the mediator at the surface of the working electrode; and

2. a meter in electrical connection with tracks 16, 18 and capable of measuring the diffusion limited current produced by oxidation of the reduced form of the mediator with the above-stated electrical potential difference is applied.

The meter will normally be adapted to apply an algorithm to the current measurement, whereby an analyte concentration is provided and visually displayed. Improvements in such power source, meter, and biosensor system are the subject of commonly assigned U.S. Pat. No. 4,963,814, issued Oct. 16, 1990; U.S. Pat. No. 4,999,632, issued Mar. 12, 1991; U.S. Pat. No. 4,999,582, issued Mar. 12, 1991; U.S. Pat. No. 5,243,516, issued Sep. 7, 1993; U.S. Pat. No. 5,352,351, issued Oct. 4, 1994; U.S. Pat. No. 5,366,609, issued Nov. 22, 1994; White et al., U.S. Pat. No. 5,405,511, issued Apr. 11, 1995; and White et al., U.S. Pat. No. 5,438,271, issued Aug. 1, 1995, the disclosures of which are expressly incorporated herein by reference.

Many fluid samples may be analyzed. For example, human body fluids such as whole blood, plasma, sera, lymph, bile, urine, semen, cerebrospinal fluid, spinal fluid, lacrimal fluid and stool specimens as well as other biological fluids readily apparent to one skilled in the art may be measured. Fluid preparations of tissues can also be assayed, along with foods, fermentation products and environmental substances, which potentially contain environmental contaminants. Preferably, whole blood is assayed with this invention.

After reaction is complete, a power source (e.g., a battery) applies a potential difference between electrodes. When the potential difference is applied, the amount of oxidized form of the mediator at the auxiliary electrode and the potential difference must be sufficient to cause diffusion-limited electro-oxidation of the reduced form of the mediator at the surface of the working electrode. A current measuring meter (not shown) measures the diffusion-limited current generated by the oxidation of the reduced form of the mediator at the surface of the working electrode. The measured current may be accurately correlated to the concentration of the analyte in sample when the following requirements are satisfied:

1. The rate of oxidation of the reduced form of the mediator is governed by the rate of diffusion of the reduced form of the mediator to the surface of the working electrode.

2. The current produced is limited by the oxidation of reduced form of the mediator at the surface of the working electrode.

To manufacture biosensor 10 a roll of metallized film is fed through guide rolls into an ablation/washing and drying station. A laser system capable of ablating substrate 14 is known to those of ordinary skill in the art. Non-limiting examples of which include excimer lasers, with the pattern of ablation controlled by mirrors, lenses, and masks. A non-limiting example of such a system is the LPX-300 or LPX-200 both commercially available from LPKF Laser Electronic GmbH, of Garbsen, Germany.

In the laser ablator, the metallic layer of the metallized film is ablated in pre-determined patterns, to form a ribbon of isolated electrode sets. The metallized film is further ablated, after the isolated electrode sets are formed to create recesses 34 positioned adjacent to each electrochemical area. The ribbon is then passed through more guide rolls, with a tension loop and through an optional optical or electrical inspection system. This inspection system is used for quality control in order to check for defects.

Reagent 20 is compounded and applied in a liquid form to the center of the electrochemical area at a dispensing and drying station. Reagent application techniques are well known to one of ordinary skill in the art as described in U.S. Pat. No. 5,762,770, the disclosure of which is expressly incorporated herein by reference. It is appreciated that reagent may be applied to the electrochemical area in a liquid or other form and dried or semi-dried onto the center of the electrochemical the electrochemical area in accordance with this disclosure.

In addition, a roll of cover material is fed into a laser ablator system as described above. In the laser ablator, the cover material is ablated in pre-determined channel patterns to form a ribbon of channel sets. Each channel set includes a flow channel 62 that is ablated to a depth of about 84 μm at first floor portion 36 and 16 μm at second floor portion 38. In addition, each channel set includes secondary channels 64 that are each ablated to a depth of about 16 μm. The cover material is then fed into a punching station where adhesive-dispense aperture 70 is punched through each secondary channel 64.

The ribbon of channel sets is unwound and fed into a sensor assembly station along with the reagent-coated bottom substrate. Cover 12 is placed on substrate 14 to cover reagent 20. Next, adhesive is dispensed through each aperture 70 into the secondary channels 64 while the cover 12 and substrate 14 are being compressed. It is appreciated that a number of commercially available dispense units may be used to apply the adhesive into apertures 70 in accordance with this disclosure. The assembled and time-cured material is then cut to form individual biosensors 10, which are sorted and packed into vials, each closed with a stopper, to give packaged sensor strips.

Although ablating channels 62, 64 is described herein, it is appreciated that the method of carving channels 62, 64 in cover 12 is also not limited. For example, the channels may be carved by etching (e.g., using photolithographic methods) or otherwise removing a portion of the surface of cover 12. In addition, the dimensions of the channels can vary based on the amount of sample to be analyzed and the surface area of the testing area.

The processes and products described above include disposable biosensor, especially for use in diagnostic devices. Also included, however, are electrochemical sensors for non-diagnostic uses, such as measuring an analyte in any biological, environmental, or other sample. As discussed above, biosensor 10 can be manufactured in a variety of shapes and sizes.

In use, a user of biosensor 10 places a finger on concave ends 60, 76. Capillary forces pull a liquid sample from ends 60, 76 through first portion 72 of channel 62. Walls 46 in first portion 72 of channel 62 converge as they approach second portion 74, increasing the capillary forces applied to the liquid sample. Thus, the liquid sample passes through the converging first portion 72 and encounters second portion 74 of channel 62 and reagent 20. Liquid sample dissolves reagent 20 and engages electrode array 78, where the electrochemical reaction takes place.

Referring now to FIGS. 6-9, biosensor 110 is provided in accordance with this invention. Biosensor 110 includes a cover 112, bottom substrate 114, and reagent 20. Biosensor 110 is preferably rectangular in shape. It is appreciated, however, that biosensor 110 can assume any number of shapes in accordance with this disclosure. Biosensor 110 is preferably produced from rolls of material. Thus, the selection of materials for the construction of biosensor 110 necessitates the use of materials that are sufficiently flexible for roll processing, but which are still rigid enough to give a useful stiffness to finished biosensor 110.

Cover 112 of biosensor 110 includes a first surface 148 facing substrate 114 and an opposite second surface 150. See FIGS. 6-7. In addition, cover 112 has opposite ends 152, 154 and edges 156, 158 extending between ends 152, 154. End 152 has a generally concave portion 160 that extends between edges 156, 158 in order to accommodate a user's finger. Cover 112 is preferably a polyester, a non-limiting example of which is 7 mil thick ST505 MELINEX® polyester film commercially available from E.I. DuPont de Nemours, Wilmington, Del.

Substrate 114 is similar to substrate 14, except that, upon assembly of biosensor 110, surface 22 is not completely coated with an electric conductor. Instead, surface 22 is exposed between about electrodes 16, 18. See, FIG. 6.

Cover 112 is coupled to substrate 114 by an adhesive 116 that is coated on either substrate 114 or cover 112. Adhesive is preferably an adhesive as described above with reference to biosensor 10 or a thermoset adhesive. A non-limiting example of a suitable thermoset adhesive is a mixture of 95% wt./wt. of Item #38-868 polyurethane and 5% wt./wt. Item #38-8569 isocyanate both commercially available from National Starch& Chemical, a Member of ICI Group, Bridgewater, N.J. It is appreciated that cover 112 may be coupled to bottom substrate 114 using a wide variety of commercially available adhesives as well as heat sealing, or ultrasonic methods of joining cover 112 and substrate may be used to couple cover 112 and substrate 114 together in accordance with this disclosure.

Additionally, as shown in FIG. 7, a flow channel 162 is carved in first surface 148 of cover 112. Channel 162 extends between ends 152, 154. Channel 162 includes a first floor portion 136 and a second floor portion 138 define channel 162. Opposite walls 146 extend from first floor portion 136 and opposite walls 140 extend from second floor portion 138. First floor portion 136 and walls 146 define first portion 172 of channel and second floor portion 138 and walls 140 define second portion 174 of channel 162.

Walls 140 that extend from first floor portion 136 have a first height as shown by arrows 142 and walls 140 extending from second floor portion 138 have a second height as shown by arrows 144. First height 142 is greater than the second height 144, so that a liquid sample traveling in channel 162 encounters a greater capillary force as it enters second portion 174 of channel 162. Therefore, channel 162 acts to draw the liquid sample away from concave portion 160 and toward reagent 20 positioned spaced-apart from end 152. The height and width of first and second channel portions 136, 138 is similar to that of respective first and second portions 36, 38 of channel 38. It is appreciated that channel 162 may be formed with a single height, or that it may have a variety of heights in accordance with this disclosure.

To manufacture biosensor 110 a roll of metallized film is fed through guide rolls into an ablation/washing and drying station as described above with reference to biosensor 10. In the laser ablator, the metallic layer of the metallized film is ablated in pre-determined electrode patterns, to form a ribbon of electrode sets. The metallized film is further ablated to create recesses 34 positioned adjacent to each electrochemical area. The ribbon may be optically or electrically inspected as described above with reference to biosensor 10. Reagent 20 is dispensed on substrate 114 as described above with reference to biosensor 10. Additionally, the thermoset adhesive is coated substrate 114 on either side of area 78. It is appreciated that a number of commercially available dispense units may be used to apply the adhesive onto substrate 114 in accordance with this disclosure.

Further, a roll of cover material is fed into a laser system as described above with reference to biosensor 10. In the laser ablator, the cover material is ablated to form a row of spaced-apart channels 162. Each channel 162 is ablated to a depth of about 84 μm at a first floor portion 36 and 16 μm at a second floor portion 38. The cover material with spaced-apart rows of channels 162 is unwound and fed into a sensor assembly station along with the ribbon of reagent-coated bottom substrates.

The cover material is aligned with the ribbon of reagent-coated bottom substrates so that each cover 112 extends across each reagent 20. Next, a hot iron (not shown) of appropriate desirable shape and size is placed upon surface 150 of each cover 112 on either side of channel 162 to couple cover 112 and substrate 114 together. The assembled material is then cut to form individual biosensors 110, which are sorted and packed into vials, each closed with a stopper, to give packaged sensor strips.

The method of carving channel 162 in cover 112 is also not limited. For example, the channels may be carved by etching (e.g., using photolithographic methods) or otherwise removing a portion of the surface of cover 12. In addition, the dimensions of the channels can vary based on the amount of sample to be analyzed and the surface area of the testing area.

The processes and products described above include disposable biosensor, especially for use in diagnostic devices. Also included, however, are electrochemical sensors for non-diagnostic uses, such as measuring an analyte in any biological, environmental, or other sample. As discussed above, biosensor 110 can be manufactured in a variety of shapes and sizes.

In use, a user of biosensor 110 places a finger on concave ends 160, 76. Capillary forces pull a liquid sample from ends 160, 76 through first portion 172 of channel 162. Walls 146 in first portion 172 of channel 162 converge as they approach second portion 174, increasing the capillary forces applied to the liquid sample. Thus, the liquid sample passes through the converging first portion 172 and encounters second portion 174 of channel 162 and reagent 20. Liquid sample dissolves reagent 20 and engages electrode array 178, where the electrochemical reaction takes place.

As shown in FIG. 10, a biosensor 210 is provided in accordance with another aspect of the present invention. Biosensor 210 includes a cover 212, a bottom substrate 214, and reagent 20. Biosensor 210 is preferably rectangular in shape and formed from materials that are similar to biosensors 10 and 110.

Cover 212 of biosensor 210 includes a flow channel 262 that is carved in first surface 48. Flow channel 262 extends between an opening 264 and an air vent 266. Substrate 214 supports tracks 16, 18 and reagent 20. Electrode array 78 and the reagent that covers array 78, is positioned to lie within channel 262 between opening 264 and air vent 266. Channel 262 is formed to have two floor portions having heights that are similar to channel 10. It is appreciated that channel 262 may be formed with a single height, or that it may have a variety of heights in accordance with this disclosure.

To manufacture biosensor 210 electrodes 16, 18 are formed on substrate 214, reagent 20 is applied to electrodes 16, 18 and thermoset adhesive is coated on substrate 214 in a manner similar to that described above with reference to biosensor 110.

Further, a roll of cover material is fed into a laser system as described above with reference to biosensor 10. In the laser ablator, the cover material is ablated to form a row of spaced-apart channels 262. Each channel 262 is ablated to a depth of about 84 μm at a first floor portion 36 and 16 μm at a second floor portion 38. The cover material with spaced-apart rows of channels 262 is unwound and fed into a sensor assembly station along with the ribbon of reagent-coated bottom substrates.

The cover material is aligned with the ribbon of reagent-coated bottom substrates so that each cover 212 extends across each reagent 20. Next, a hot iron (not shown) of appropriate desirable shape and size is placed upon surface 50 of each cover 212 on either side of channel 262 to couple cover 212 and substrate 214 together. The assembled material is then cut to form individual biosensors 210, which are sorted and packed into vials, each closed with a stopper, to give packaged sensor strips.

The method of carving channel 262 in cover 212 is also not limited. For example, the channels may be carved by etching (e.g., using photolithographic methods) or otherwise removing a portion of the surface of cover 212. In addition, the dimensions of the channels can vary based on the amount of sample to be analyzed and the surface area of the testing area.

The processes and products described above include disposable biosensor, especially for use in diagnostic devices. Also included, however, are electrochemical sensors for non-diagnostic uses, such as measuring an analyte in any biological, environmental, or other sample. As discussed above, biosensor 210 can be manufactured in a variety of shapes and sizes.

Although the invention has been described in detail with reference to a preferred embodiment, variations and modifications exist within the scope and spirit of the invention as described and defined in the following claims.

Bhullar, Raghbir S., Walling, Douglas P., Hill, Brian S.

Patent Priority Assignee Title
10034628, Dec 12 2005 Sanofi-Aventis Deutschland GmbH Low pain penetrating member
10070822, Nov 04 2008 PHC HOLDINGS CORPORATION Measurement Device
10687762, Nov 04 2008 PHC HOLDINGS CORPORATION Measurement device
11751815, Nov 04 2008 PHC HOLDINGS CORPORATION Measurement device
7297151, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling with improved sensing
7305896, Sep 01 2003 ABBOTT RAPID DIAGNOSTICS INTERNATIONAL UNLIMITED COMPANY Capillary fill test device
7316700, Jun 12 2002 Sanofi-Aventis Deutschland GmbH Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
7344507, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet actuation
7344894, Oct 16 2001 Sanofi-Aventis Deutschland GmbH Thermal regulation of fluidic samples within a diagnostic cartridge
7374544, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7410468, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7481776, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7491178, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7510985, Oct 26 2005 LPKF LASER & ELECTRONICS AG Method to manufacture high-precision RFID straps and RFID antennas using a laser
7524293, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7537571, Jun 12 2002 Sanofi-Aventis Deutschland GmbH Integrated blood sampling analysis system with multi-use sampling module
7547287, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7563232, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7582063, Nov 21 2000 Sanofi-Aventis Deutschland GmbH Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
7582099, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7604592, Jun 14 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for a point of care device
7608042, Sep 09 2004 INTELLECTUAL DISCOVERY CO , LTD Blood monitoring system
7648468, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7666149, Dec 04 1997 Sanofi-Aventis Deutschland GmbH Cassette of lancet cartridges for sampling blood
7674232, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7682318, Jun 12 2002 Sanofi-Aventis Deutschland GmbH Blood sampling apparatus and method
7699791, Jun 12 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving success rate of blood yield from a fingerstick
7713214, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with optical analyte sensing
7717863, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7731729, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7822454, Jan 03 2005 AUTO INJECTION TECHNOLOGIES LLC Fluid sampling device with improved analyte detecting member configuration
7833171, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7841992, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
7850621, Jun 07 2004 AUTO INJECTION TECHNOLOGIES LLC Method and apparatus for body fluid sampling and analyte sensing
7850622, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
7862520, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Body fluid sampling module with a continuous compression tissue interface surface
7874994, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7892183, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling and analyte sensing
7901362, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7909774, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7909775, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
7909777, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7909778, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7914465, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7938787, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7959582, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
7976476, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Device and method for variable speed lancet
7981055, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
7981056, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
7988644, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
7988645, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
8007446, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8016774, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8062231, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8079960, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8092385, May 23 2006 INTELLECTUAL DISCOVERY CO , LTD Fluid access interface
8123700, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
8162853, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8197421, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8197423, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8202231, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8206317, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8206319, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8211037, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8216154, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8221334, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8251921, Jun 06 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling and analyte sensing
8267870, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for body fluid sampling with hybrid actuation
8282576, Sep 29 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for an improved sample capture device
8282577, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
8296918, Dec 31 2003 AUTO INJECTION TECHNOLOGIES LLC Method of manufacturing a fluid sampling device with improved analyte detecting member configuration
8333710, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8337419, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8337420, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8343075, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8360991, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8382682, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8382683, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8388551, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for multi-use body fluid sampling device with sterility barrier release
8403864, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8414503, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
8430828, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
8435190, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8439872, Mar 30 1998 Sanofi-Aventis Deutschland GmbH Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
8579831, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8597570, Nov 04 2008 PHC HOLDINGS CORPORATION Measurement device, insulin infusion device, measurement method, method for controlling insulin infusion device, and program
8622930, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8641643, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Sampling module device and method
8652831, Dec 30 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for analyte measurement test time
8668656, Dec 31 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
8679033, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8690796, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8702624, Sep 29 2006 AUTO INJECTION TECHNOLOGIES LLC Analyte measurement device with a single shot actuator
8721671, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Electric lancet actuator
8753290, Mar 27 2009 INTELLECTUAL DISCOVERY CO , LTD Fluid transfer system and method
8828203, May 20 2005 SANOFI S A Printable hydrogels for biosensors
8845550, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
8905945, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
8945910, Sep 29 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for an improved sample capture device
8965476, Apr 16 2010 Pelikan Technologies, Inc Tissue penetration device
9034639, Dec 30 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus using optical techniques to measure analyte levels
9046479, Jun 24 2008 PHC HOLDINGS CORPORATION Biosensor, method of producing the same and detection system comprising the same
9072842, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9089294, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Analyte measurement device with a single shot actuator
9089678, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9144401, Dec 12 2005 Sanofi-Aventis Deutschland GmbH Low pain penetrating member
9186468, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9226699, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Body fluid sampling module with a continuous compression tissue interface surface
9248267, Oct 04 2005 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
9261476, May 20 2004 Sanofi SA Printable hydrogel for biosensors
9314194, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Tissue penetration device
9351680, Oct 14 2003 AUTO INJECTION TECHNOLOGIES LLC Method and apparatus for a variable user interface
9375169, Jan 30 2009 Sanofi-Aventis Deutschland GmbH Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
9386944, Apr 11 2008 Sanofi-Aventis Deutschland GmbH Method and apparatus for analyte detecting device
9427532, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Tissue penetration device
9498160, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method for penetrating tissue
9560993, Nov 21 2001 Sanofi-Aventis Deutschland GmbH Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
9561000, Dec 31 2003 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
9622690, Nov 04 2008 PHC HOLDINGS CORPORATION Measurement device
9694144, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Sampling module device and method
9724021, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9795334, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Method and apparatus for penetrating tissue
9795747, Jun 02 2010 Pelikan Technologies, Inc Methods and apparatus for lancet actuation
9802007, Jun 12 2001 Sanofi-Aventis Deutschland GmbH Methods and apparatus for lancet actuation
9820684, Jun 03 2004 Sanofi-Aventis Deutschland GmbH Method and apparatus for a fluid sampling device
9839386, Apr 19 2002 Sanofi-Aventis Deutschland GmbH Body fluid sampling device with capacitive sensor
9855011, Nov 04 2008 PHC HOLDINGS CORPORATION Measurement device
Patent Priority Assignee Title
4081653, Dec 27 1976 AT & T TECHNOLOGIES, INC , Removal of thin films from substrates by laser induced explosion
4131484, Feb 13 1978 AT & T TECHNOLOGIES, INC , Frequency adjusting a piezoelectric device by lasering
4294679, Jul 14 1979 Robert Bosch GmbH Flat electrochemical sensor, and method of its manufacture
4414059, Dec 09 1982 International Business Machines Corporation Far UV patterning of resist materials
4684437, Oct 31 1985 International Business Machines Corporation Selective metal etching in metal/polymer structures
4865873, Sep 15 1986 General Electric Company Electroless deposition employing laser-patterned masking layer
4874500, Jul 15 1987 MICROBIONICS, INC Microelectrochemical sensor and sensor array
4897173, Jun 21 1985 Matsushita Electric Industrial Co., Ltd. Biosensor and method for making the same
4902138, Apr 04 1987 HARTMAN & BRAUN AG Measuring component concentration in a gas blend
4957582, Mar 16 1989 CLINICAL DIAGNOSTIC SYSTEMS INC Capillary transport zone coated with adhesive
4963814, Dec 15 1989 Roche Diabetes Care, Inc Regulated bifurcated power supply
4999582, Dec 15 1989 Roche Diabetes Care, Inc Biosensor electrode excitation circuit
4999632, Dec 15 1989 Roche Diabetes Care, Inc Analog to digital conversion with noise reduction
5018164, Sep 12 1989 Hughes Electronics Corporation Excimer laser ablation method and apparatus for microcircuit fabrication
5089103, Dec 01 1989 Agilent Technologies Inc Electrophoresis capillary with agarose
5104480, Oct 12 1990 Lockheed Martin Corporation Direct patterning of metals over a thermally inefficient surface using a laser
5120420, Mar 31 1988 MATSUSHITA ELECTRIC INDUSTRIAL CO , LTD Biosensor and a process for preparation thereof
5165407, Apr 19 1990 UNIVERSITY OF KANSAS, THE, Implantable glucose sensor
5243516, Dec 15 1989 Roche Diabetes Care, Inc Biosensing instrument and method
5264103, Oct 18 1991 Panasonic Corporation Biosensor and a method for measuring a concentration of a substrate in a sample
5266179, Jul 20 1990 Matsushita Electric Industrial Co., Ltd.; Kyoto Daiichi Kagaku Co., Ltd. Quantitative analysis method and its system using a disposable sensor
5288636, Dec 15 1989 Roche Diagnostics Corporation Enzyme electrode system
5334279, Apr 08 1993 Method and apparatus for making printed circuit boards
5336388, Dec 26 1991 RADIOMETER CALIFORNIA, INC Analyte and pH measuring sensor assembly and method
5352351, Jun 08 1993 Roche Diabetes Care, Inc Biosensing meter with fail/safe procedures to prevent erroneous indications
5366609, Jun 08 1993 Roche Diabetes Care, Inc Biosensing meter with pluggable memory key
5382346, May 17 1991 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
5384028, Aug 28 1992 NEC Corporation Biosensor with a data memory
5390412, Apr 08 1993 Method for making printed circuit boards
5391250, Mar 15 1994 MEDTRONIC MINIMED, INC Method of fabricating thin film sensors
5395504, Feb 04 1993 Asulab S.A. Electrochemical measuring system with multizone sensors
5405511, Jun 08 1993 Roche Diabetes Care, Inc Biosensing meter with ambient temperature estimation method and system
5413690, Jul 23 1993 Roche Diabetes Care, Inc Potentiometric biosensor and the method of its use
5414224, Apr 01 1991 AKTSIONERNOE OBSCHESTVO OTKRYTOGO TIPA VNIIETO Multilayer printed circuit board and method of manufacturing same
5426850, Nov 29 1991 HITACHI CHEMICAL COMPANY, LTD LIMITED PARTNERSHIP OF JAPAN Fabrication process of wiring board
5437999, Feb 22 1994 Roche Diabetes Care, Inc Electrochemical sensor
5451722, Apr 08 1993 Printed circuit board with metallized grooves
5465480, Mar 27 1993 Bruker Saxonia Analytik GmbH Method of manufacturing a gating grid
5496453, May 17 1991 Kyoto Daiichi Kagaku Co., Ltd. Biosensor and method of quantitative analysis using the same
5508171, Dec 15 1989 Roche Diabetes Care, Inc Assay method with enzyme electrode system
5509410, Jun 06 1983 MediSense, Inc. Strip electrode including screen printing of a single layer
5512489, Dec 04 1989 PALINTEST LTD Microelectrodes and amperometric assays
5575930, Oct 07 1992 Ecossensors Limited Method of making gas permeable membranes for amperometric gas electrodes
5576073, Apr 23 1994 LPKF LASER & ELECTRONICS AKTIENGESELLSCHAFT Method for patterned metallization of a substrate surface
5589326, Dec 30 1993 Roche Diabetes Care, Inc Osmium-containing redox mediator
5593739, Feb 14 1995 LPKF LASER & ELECTRONICS AKTIENGESELLSCHAFT Method of patterned metallization of substrate surfaces
5628890, Sep 27 1995 MEDISENSE, INC Electrochemical sensor
5635054, Dec 04 1989 ARROWHEAD CENTER, INC Microelectrodes and amperometric assays
5682884, May 05 1983 MediSense, Inc. Strip electrode with screen printing
5708247, Feb 14 1996 Lifescan Scotland Limited Disposable glucose test strips, and methods and compositions for making same
5739039, Dec 04 1989 PALINTEST LTD Microelectrodes and amperometric assays
5755953, Dec 18 1995 Abbott Laboratories Interference free biosensor
5758398, Jun 27 1995 PHYCOMP HOLDING B V Method of manufacturing multilayer electronic components
5759364, May 02 1997 Bayer HealthCare LLC Electrochemical biosensor
5762770, Feb 22 1994 Roche Diabetes Care, Inc Electrochemical biosensor test strip
5773319, Dec 05 1996 Electronics and Telecommunications Research Institute Method for producing a hydrogenated vertical-cavity surface-emitting laser
5798031, May 12 1997 Bayer Corporation Electrochemical biosensor
5948289, Nov 29 1995 Matsushita Electric Industrial Co., Ltd. Laser beam machining method
5948695, Jun 17 1997 Roche Diabetes Care, Inc Device for determination of an analyte in a body fluid
5955179, Sep 21 1995 LPKF LASER & ELECTRONICS AG Coating for the structured production of conductors on the surface of electrically insulating substrates
5956572, Aug 26 1996 Sharp Kabushiki Kaisha Method of fabricating integrated thin film solar cells
5965001, Jul 03 1996 Caliper Technologies Corporation Variable control of electroosmotic and/or electrophoretic forces within a fluid-containing structure via electrical forces
6004441, Jul 10 1997 PHC HOLDINGS CO , LTD ; PANASONIC HEALTHCARE HOLDINGS CO , LTD Biosensor
6068748, Apr 09 1993 Siemens Healthcare Diagnostics Inc Extended use planar sensors
6103033, Mar 04 1998 THERASENSE, INC Process for producing an electrochemical biosensor
6134461, Mar 04 1998 Abbott Diabetes Care Inc Electrochemical analyte
6165594, Jan 15 1998 3M INNOAVATIVE PROPERTIES COMPANY Multilayer, temperature resistant, composite label
6175752, Apr 30 1998 Abbott Diabetes Care Inc Analyte monitoring device and methods of use
6203952, Jan 14 1999 3M Innovative Properties Company Imaged article on polymeric substrate
6258229, Jun 02 1999 Nova Biomedical Corporation Disposable sub-microliter volume sensor and method of making
6287451, Jun 02 1999 Nova Biomedical Corporation Disposable sensor and method of making
6299757, Oct 08 1998 Abbott Diabetes Care Inc Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
6309526, Jul 10 1997 PHC HOLDINGS CO , LTD ; PANASONIC HEALTHCARE HOLDINGS CO , LTD Biosensor
6338790, Oct 08 1998 ABBOTT DIABETES CARE, INC Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
6399258, Jan 14 1999 3M Innovative Properties Company Method for patterning thin films
6662439, Oct 04 1999 Roche Diabetes Care, Inc Laser defined features for patterned laminates and electrodes
6696008, May 25 2000 Westar Photonics Inc. Maskless laser beam patterning ablation of multilayered structures with continuous monitoring of ablation
20010006766,
20030088166,
DE4233178,
EP376721,
EP480703,
EP875754,
EP964059,
EP1098000,
EP1152239,
EP1195441,
EP1202060,
EP1203956,
EP1288654,
JP10241992,
JP10275959,
JP10303444,
JP1052780,
JP11088784,
JP11297890,
JP2000121594,
JP5315703,
JP56100451,
JP7290751,
JP766499,
JP9260697,
WO42472,
WO73778,
WO73785,
WO125775,
WO136953,
WO175438,
WO192884,
WO2086483,
WO227074,
WO9102391,
WO9108474,
WO9522881,
WO9835225,
WO9849773,
WO9855856,
WO9913101,
WO9930152,
WO9945387,
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jan 08 2003Roche Diagnostics Corporation(assignment on the face of the patent)
Jan 01 2004Roche Diagnostics CorporationRoche Diagnostics Operations, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0152150061 pdf
Mar 02 2015Roche Diagnostics Operations, IncRoche Diabetes Care, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0360080670 pdf
Date Maintenance Fee Events
Sep 18 2008M1551: Payment of Maintenance Fee, 4th Year, Large Entity.
Oct 04 2012M1552: Payment of Maintenance Fee, 8th Year, Large Entity.
Feb 03 2017REM: Maintenance Fee Reminder Mailed.
Jun 28 2017EXP: Patent Expired for Failure to Pay Maintenance Fees.


Date Maintenance Schedule
Jun 28 20084 years fee payment window open
Dec 28 20086 months grace period start (w surcharge)
Jun 28 2009patent expiry (for year 4)
Jun 28 20112 years to revive unintentionally abandoned end. (for year 4)
Jun 28 20128 years fee payment window open
Dec 28 20126 months grace period start (w surcharge)
Jun 28 2013patent expiry (for year 8)
Jun 28 20152 years to revive unintentionally abandoned end. (for year 8)
Jun 28 201612 years fee payment window open
Dec 28 20166 months grace period start (w surcharge)
Jun 28 2017patent expiry (for year 12)
Jun 28 20192 years to revive unintentionally abandoned end. (for year 12)